Alon Bloomenfeld

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel.

Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona.

Orbix Medical Ltd. manufactures and distributes medical equipment. It offers Orbishape and Orbisymm. The company was founded by Eyal Gur in 2004 and is headquartered in Tel Aviv, Israel.